Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Filings indexed 449 across all filing types
Latest filing 2024-08-07 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the schedule of an Analysts/Investors Earnings Call for the quarter ended June 30, 2024. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events including earnings calls. The document does not contain any financial data or results itself but announces the timing and details of the upcoming earnings call. It also includes dial-in details and contact information for the call. Given the content and length (3661 characters), this is a notification about an earnings call, not the transcript or the earnings release itself. Therefore, the appropriate classification is Call Transcript (CT) since it is about the earnings call event, but since it is only the schedule/intimation and not the transcript, the best fit is Regulatory Filings (RNS) as a general announcement. However, the document specifically announces the schedule of the earnings call, which aligns with the category of Call Transcript (CT) announcements. But since it is only the schedule and not the transcript, and no financial data is included, the best classification is Regulatory Filings (RNS).
2024-08-07 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is an intimation about a scheduled Board Meeting to consider and approve unaudited financial results for the quarter ended June 30, 2024. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) regarding disclosure of such meetings. The document does not contain any financial data or results itself, but is a notice of an upcoming board meeting where financial results will be approved. The document length is short (2335 characters) and it is clearly an announcement rather than a report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2024-08-06 English
Board Meeting — ORCHID PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2024-08-06 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India Limited and BSE Limited) regarding the dispatch of the Notice of the 31st Annual General Meeting (AGM) and the Annual Report of Orchid Pharma Limited for the fiscal year 2023-24. It references regulatory compliance with SEBI (Securities and Exchange Board of India) regulations and mentions the publication of a newspaper notice about the dispatch of the Notice and Annual Report. The document does not contain the Annual Report itself but rather announces that the Notice and Annual Report have been dispatched and are available on the company's website. The document length is about 15,000 characters, but the content is primarily an announcement of the dispatch and publication of the Notice and Annual Report, not the report itself. According to the "Menu vs Meal" rule, such a document is classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K).
2024-07-28 English
Shareholders meeting
Annual Report Classification · 95% confidence The document is dated July 27, 2024, and references the Annual Report and Notice of the 31st Annual General Meeting (AGM) for the financial year ended March 31, 2024. It mentions compliance with SEBI Listing Regulations and includes the Annual Report with financial statements and Board of Directors' reports. The text also includes detailed corporate information, board composition, and governance details typical of an Annual Report. The document length is 15,000 characters, indicating it is the full report rather than a brief announcement. Therefore, this document is the full Annual Report for FY 2023-24. FY 2024
2024-07-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short communication from the company to stock exchanges regarding a correction in the cut-off date for e-voting eligibility for the upcoming Annual General Meeting (AGM). It references the AGM date and voting procedures but does not contain any financial data, detailed report content, or results. The document is under 5,000 characters and serves as an update or announcement related to the AGM process rather than the AGM materials themselves. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about the AGM voting cut-off date correction, not the AGM information or voting results themselves.
2024-07-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.